Alan Anz, MD
Adult Reconstructive Orthopaedic Surgery · Columbia, MONPI 1366553323
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,523 of the $9,143 with a category attached, or 60.4%. Smith+Nephew accounts for 65.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $5,449 and has fallen 66.4% since, to $1,830 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in MO, where the typical reported total is $10,569.
Across 63 payments — averaging $145.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Zimmer Biomet$1K
- Hikma Pharmaceuticals USA$423
- Microport Orthopedics Inc$343
- Medacta USA, Inc.$299
- Heraeus Medical, LLC.$164
- plus $595 from 16 others
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$2K
What the payments were for
- Consulting fees$5,52360%
- Travel & lodging$1,62218%
- Food & beverage$1,99722%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $5,992 |
| Zimmer Biomet | 11 | $1,327 |
| Hikma Pharmaceuticals USA | 1 | $423 |
| Microport Orthopedics Inc | 3 | $343 |
| Medacta USA, Inc. | 1 | $299 |
| Heraeus Medical, LLC. | 4 | $164 |
| Pacira Therapeutics, Inc. | 6 | $138 |
| Johnson & Johnson | 4 | $83 |
| Heron Therapeutics, Inc. | 4 | $59 |
| Stryker | 1 | $58 |
| Elite Orthopedics, LLC | 1 | $32 |
| Hospira, Inc. | 2 | $32 |
| Davol Inc. | 1 | $31 |
| Vertex | 1 | $26 |
| Kerecis Limited | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Bone Support Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Medline Industries LP | 1 | $13 |
| KCI USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxford$790
- Journey II$629
- COMBOGESIC IV$423
- GMK SPHERE$299
- MPO Medial Pivot Knee$244
- REDAPT Revision Hip System$150
- Navio Surgical System$142
- Persona$124
- REAL INTELLIGENCE$104
How this compares
$9,143 in reported general payments places this provider in the 45th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.
See all adult reconstructive orthopaedic surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $10,874 |
| Celecoxib | 114 | $2,932 |
| Tramadol Hcl | 105 | $493 |
| Oxycodone Hcl | 59 | $398 |
| Ondansetron Hcl | 19 | $118 |
| Cephalexin | 65 | $111 |
| Meloxicam | 24 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $10,87421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.
Other adult reconstructive orthopaedic surgery in Columbia
- Thomas AletoColumbia$669K
- Ajay AggarwalColumbia$78K
- Samuel ThompsonColumbia$30K
- James KeeneyColumbia$22K
- Elie GhanemColumbia$8K
- Jeffrey MillesColumbia$5K
- David HockmanColumbia$585
- Benjamin HoltColumbia$104
- Peter BuchertColumbia$46
- Robert BarrackSaint Louis$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.